Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins
Pharmaceutical Research · 2024
DOI: 10.1007/s11095-024-03700-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Baikuntha Aryal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Biochemistry, Division of Biotechnology Research and Review III, Office of Biotechnology Products, Office of Pharmaceutical Qua…. Hauptthemen laut MEDLINE: Polysorbates, Surface-Active Agents, Lipase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Polysorbates are the most commonly used surfactants in formulations to stabilize therapeutic proteins against interfacial stresses. Polysorbates can undergo oxidative or enzyme-mediated hydrolytic degradation to produce free fatty acids (FFAs) and subvisible particles in formulations. To determine which product related variables contribute to PS20 degradation, we investigated the effects of storage temperature, formulation, pH, presence of hydrolytic enzymes, and specific fatty acid composition on different grades of PS20 in relation to their PS20 degradation profile and consequently the quality of protein drug products.
Methods
Bevacizumab and T-DM1 were reformulated in the freshly prepared therapeutic protein formulations containing either compendial PS20 or non-compendial PS20 with high % lauric acid and spiked with exogenous esterase or lipase. The release of FFAs and formation of particles were monitored at 4°C and 37°C. Protein quality was assessed for secondary structures, purity, and biological activity.
Results
Hydrolytic release of FFAs and formation of subvisible particles were found to be dependent on grades of PS20, types of enzymes used, incubation temperature, and pH. Esterase- or lipase-mediated degradation of PS20 and formation of subvisible particles in drug formulation showed no significant impact on the biological activity and stability of therapeutic proteins against degradation or aggregation.
Conclusions
Our study suggests that degradation of PS20 and formation of FFA particles depend on the fatty acid composition of PS20, types of hydrolytic enzymes, pH, and temperature. The presence of FFA subvisible particles showed no significant impact on the purity and biological activity of the therapeutic proteins under the tested conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Applied Biochemistry, Division of Biotechnology Research and Review III, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administr…
Zitieren
APA
Aryal, B., Lehtimaki, M., & Rao, V. A. (2024). Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03700-7
Vancouver
Aryal B, Lehtimaki M, Rao VA. Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03700-7
BibTeX
@article{Aryal2024,
author = {Aryal, Baikuntha and Lehtimaki, Mari and Rao, V Ashutosh},
title = {Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins},
journal = {Pharmaceutical Research},
year = {2024},
doi = {10.1007/s11095-024-03700-7}
}
EUVIMED